Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH vs ASTRAZENECA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH ASTRAZENECA PHARMA WYETH/
ASTRAZENECA PHARMA
 
P/E (TTM) x 27.7 95.5 29.0% View Chart
P/BV x 11.3 22.7 49.6% View Chart
Dividend Yield % 10.9 0.3 3,612.8%  

Financials

 WYETH   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    WYETH
Mar-14
ASTRAZENECA PHARMA
Mar-23
WYETH/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0653,620 29.4%   
Low Rs5532,438 22.7%   
Sales per share (Unadj.) Rs289.5401.2 72.2%  
Earnings per share (Unadj.) Rs38.739.7 97.4%  
Cash flow per share (Unadj.) Rs39.946.2 86.3%  
Dividends per share (Unadj.) Rs145.0016.00 906.3%  
Avg Dividend yield %17.90.5 3,392.7%  
Book value per share (Unadj.) Rs118.5234.4 50.6%  
Shares outstanding (eoy) m22.7225.00 90.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.87.5 37.0%   
Avg P/E ratio x20.976.3 27.4%  
P/CF ratio (eoy) x20.365.5 30.9%  
Price / Book Value ratio x6.812.9 52.8%  
Dividend payout %374.740.3 930.1%   
Avg Mkt Cap Rs m18,38175,718 24.3%   
No. of employees `000NANA-   
Total wages/salary Rs m3592,591 13.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m6,57710,030 65.6%  
Other income Rs m347261 133.1%   
Total revenues Rs m6,92510,291 67.3%   
Gross profit Rs m1,0231,249 81.9%  
Depreciation Rs m27163 16.8%   
Interest Rs m46 69.7%   
Profit before tax Rs m1,3391,341 99.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m460348 132.0%   
Profit after tax Rs m879993 88.5%  
Gross profit margin %15.612.5 124.9%  
Effective tax rate %34.326.0 132.3%   
Net profit margin %13.49.9 135.0%  
BALANCE SHEET DATA
Current assets Rs m3,9649,359 42.4%   
Current liabilities Rs m2,0814,844 43.0%   
Net working cap to sales %28.645.0 63.6%  
Current ratio x1.91.9 98.6%  
Inventory Days Days3549 70.9%  
Debtors Days Days27839 709.5%  
Net fixed assets Rs m8782,061 42.6%   
Share capital Rs m22750 454.4%   
"Free" reserves Rs m2,4665,811 42.4%   
Net worth Rs m2,6935,861 45.9%   
Long term debt Rs m250-   
Total assets Rs m4,84211,421 42.4%  
Interest coverage x306.0213.9 143.1%   
Debt to equity ratio x00-  
Sales to assets ratio x1.40.9 154.7%   
Return on assets %18.28.7 208.6%  
Return on equity %32.616.9 192.7%  
Return on capital %49.423.0 215.0%  
Exports to sales %0.10-   
Imports to sales %34.737.4 92.8%   
Exports (fob) Rs m8NA-   
Imports (cif) Rs m2,2813,747 60.9%   
Fx inflow Rs m8612 1.2%   
Fx outflow Rs m2,2983,747 61.3%   
Net fx Rs m-2,291-3,135 73.1%   
CASH FLOW
From Operations Rs m1,188583 203.9%  
From Investments Rs m287181 158.4%  
From Financial Activity Rs m-4,296-245 1,754.9%  
Net Cashflow Rs m-2,821519 -543.3%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.1 75.0 68.2%  
Indian inst/Mut Fund % 18.4 5.4 339.1%  
FIIs % 0.0 2.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 48.9 25.0 195.5%  
Shareholders   25,706 29,032 88.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on WYETH vs ASTRAZENECA PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

WYETH vs ASTRAZENECA PHARMA Share Price Performance

Period WYETH ASTRAZENECA PHARMA S&P BSE HEALTHCARE
1-Day -2.27% 0.01% 1.18%
1-Month 18.58% -3.61% -0.75%
1-Year 69.59% 59.20% 61.82%
3-Year CAGR 15.36% 20.50% 18.16%
5-Year CAGR 8.95% 22.18% 19.79%

* Compound Annual Growth Rate

Here are more details on the WYETH share price and the ASTRAZENECA PHARMA share price.

Moving on to shareholding structures...

The promoters of WYETH hold a 51.1% stake in the company. In case of ASTRAZENECA PHARMA the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of WYETH and the shareholding pattern of ASTRAZENECA PHARMA.

Finally, a word on dividends...

In the most recent financial year, WYETH paid a dividend of Rs 145.0 per share. This amounted to a Dividend Payout ratio of 374.7%.

ASTRAZENECA PHARMA paid Rs 16.0, and its dividend payout ratio stood at 40.3%.

You may visit here to review the dividend history of WYETH, and the dividend history of ASTRAZENECA PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.